Literature DB >> 6598050

Ischemic hepatitis: clinical features, diagnosis and prognosis.

P R Gibson, F J Dudley.   

Abstract

Nineteen episodes of ischemic hepatitis were diagnosed by hepatitic liver function tests and characteristic liver pathology in 17 patients. All patients had an acute illness associated with a likely fall in cardiac output although only five episodes were associated with documented hypotension. Right ventricular failure was severe in only four, mild in six, and absent in nine whilst left ventricular failure was clinically apparent in 16. The hepatitic illness was usually mild. No patient died as a direct result of hepatic damage, prognosis depending on the underlying cardiac or systemic disease. Liver function tests were characterised by a marked rise in serum transaminase levels with a parallel increase in serum lactic dehydrogenase of hepatic origin and a short time course of the enzyme elevation lasting 3 to 11 days. It is concluded that ischemic hepatitis is caused by poor hepatic perfusion associated with an acute fall in cardiac output; is usually a subclinical illness with little influence on prognosis, and may be accurately differentiated from viral hepatitis on clinical and biochemical criteria alone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6598050     DOI: 10.1111/j.1445-5994.1984.tb03780.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  14 in total

1.  Acute intestinal ischaemia.

Authors:  A Marston
Journal:  BMJ       Date:  1990-11-24

2.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

3.  ISCHEMIC HEPATITIS.

Authors:  Arun Tyagi; H S Pruthi
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 4.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

5.  Impact of hypoxic hepatitis on mortality in the intensive care unit.

Authors:  Valentin Fuhrmann; Nikolaus Kneidinger; Harald Herkner; Gottfried Heinz; Mariam Nikfardjam; Anja Bojic; Peter Schellongowski; Bernhard Angermayr; Maximilian Schöniger-Hekele; Christian Madl; Peter Schenk
Journal:  Intensive Care Med       Date:  2011-06-07       Impact factor: 17.440

6.  Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation.

Authors:  Y Yamakawa; M Takano; M Patel; N Tien; T Takada; G B Bulkley
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

7.  Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia.

Authors:  Hemananda Muniraman; Danielle Gardner; Jane Skinner; Anna Paweletz; Anitha Vayalakkad; Ying Hui Chee; Clare Clifford; Sunil Sanka; Vidheya Venkatesh; Anna Curley; Suresh Victor; Mark A Turner; Paul Clarke
Journal:  Eur J Pediatr       Date:  2017-07-24       Impact factor: 3.183

8.  Unmeasured anions are associated with short-term mortality in patients with hypoxic hepatitis.

Authors:  Nikolaus Kneidinger; Georg-Christian Funk; Gregor Lindner; Andreas Drolz; Peter Schenk; Valentin Fuhrmann
Journal:  Wien Klin Wochenschr       Date:  2013-07-17       Impact factor: 1.704

9.  Liver dysfunction and acute cardiocirculatory failure in children.

Authors:  E Jacquemin; E Saliba; M H Blond; A Chantepie; J Laugier
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

10.  Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients.

Authors:  Valentin Fuhrmann; Nikolaus Kneidinger; Harald Herkner; Gottfried Heinz; Mariam Nikfardjam; Anja Bojic; Peter Schellongowski; Bernhard Angermayr; Reinhard Kitzberger; Joanna Warszawska; Ulrike Holzinger; Peter Schenk; Christian Madl
Journal:  Intensive Care Med       Date:  2009-06-09       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.